Caitong International Asset Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-913
Closed -$321K – 2982
2026
Q1
$321K Buy
+913
New +$325K 0.06% 272
2025
Q4
– Sell
-284
Closed -$80.1K – 1867
2025
Q3
$80.1K Buy
284
+231
+436% +$67K 0.06% 212
2025
Q2
$14.8K Sell
53
-738
-93% -$209K 0.01% 591
2025
Q1
$246K Buy
791
+293
+59% +$86.5K 0.18% 92
2024
Q4
$130K Buy
+498
New +$148K 0.13% 171

Other funds holding AMGN

Caitong International Asset Management's AMGN Position: Q2 2026 in Review

Caitong International Asset Management sold out of Amgen (AMGN) in Q2 2026, closing a stake of 913 shares — an estimated $321K sold.

Caitong International Asset Management first reported a position in AMGN in Q4 2024 and held it in 5 quarters. The position peaked at $321K in Q1 2026. 3,164 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Caitong International Asset Management reported no remaining Amgen position as of Q2 2026 after selling out during the quarter.
  • Caitong International Asset Management sold 913 Amgen shares in Q2 2026, an estimated $321K.
  • Caitong International Asset Management first reported a position in Amgen in Q4 2024 and held it in 5 quarters.
  • Caitong International Asset Management's Amgen position peaked at $321K in Q1 2026.
  • 3,164 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.